Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Stroke
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Stroke
    Periodontal Bone Loss Associated With Risk of Stroke in Men - (DGNews)
    Silent Cerebral Infarcts a Risk Factor for Visual Field Loss in Patients With Normal-Tension Glaucoma - (DGNews)
    Some Stroke Survivors' Function Slowly Declines Over Time - (DGNews)
    TopAbstracts in Stroke 06/25/2009 - (DGNews)
    CPAP Lowers Mortality Risk in Stroke Patients With Obstructive Sleep Apnoea - (DGNews)

    News archive

     Recent webcasts/CME - Stroke
    Advancing the Standard of Care: Cardiovascular and Neurovascular Emergencies
    The Image of Age on the Choice of Antiplatelet Therapy

    Webcasts/CME archive

     Recent cases - Stroke
      Pure Sensory Stroke Form Compression of Putaminal Hemorrhage: A Case Report
      An Echocardiographic-Confirmed Case of Atrial Myxoma Causing Cerebral Embolic Ischemic Stroke: A Case Report
      Diffusion-Negative MRI in Acute Ischemic Stroke: A Case Report
      F-18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for the Diagnosis of Takayasu's Arteritis in Stroke: A Case Report
      Acute Bilateral Anterior Circulation Stroke Due to Anomalous Cerebral Vasculature: A Case Report

      Cases archive
        




      my personal edition > stroke > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Anticoagulation Therapy Reduces Stroke Frequency, Severity, and Mortality in Patients with Atrial Fibrillation

      New England Journal of Medicine (NEJM)

      09/11/2003
      By Joene Hendry


      Oral anticoagulation therapy to an international normalised ratio (INR) of 2.0 or greater reduces the frequency and severity of ischaemic stroke, as well as the risk of stroke-related death among patients with nonvalvular atrial fibrillation according to an observational study of a large cohort of patients.

      "Our data indicate that an INR of less than 2.0 will substantially increase the likelihood of death and severe disability from atrial fibrillation-related stroke," writes Elaine M. Hylek, MD, MPH, Massachusetts General Hospital, Harvard Medical School, Boston, United States and colleagues. They calculated incident ischaemic strokes in 13,559 patients with nonvalvular atrial fibrillation and the use of aspirin, no anticoagulant, or warfarin and the associated INR, as well as stroke severity and 30-day mortality in the cohort. The mean age of the patients was 78 years, 55% were women, nearly 70% of the cohort had hypertension, and about one-third had a history of congestive heart failure, coronary heart disease, or stroke.

      Among the 596 patients who experienced an ischaemic stroke, 248 (42%) were taking neither aspirin nor warfarin at the time of their stroke. Of these 22% died before discharge or were discharged with a severe deficit.

      Of the 160 (27%) patients taking aspirin at the time of their stroke, 13% died before discharge or had a severe deficit upon discharge.

      Among the 188 (32%) patients taking warfarin at the time of their stroke, the investigators report a median INR upon admission of 1.7. Overall, 62% of the warfarin users had INR values less than 2.0. Death or severe deficit was reported in 15% of the warfarin users with an INR value less than 2.0. Conversely, the warfarin users with an INR value of 2.0 or greater, 5% died before discharge or had a severe stroke-related deficit.

      The 30-day mortality rate for warfarin patients with INR values of 2.0 or greater was 6%. These rates were significantly higher among the other groups " 16% for warfarin users with INR values of 2.0 or less, 15% for aspirin users, and 24% for those not using aspirin or warfarin.

      "Our findings highlight an important incremental benefit of anticoagulation," Dr. Hylek and colleagues write, "strokes that occur among patients with adequate anticoagulation are far less likely to result in severe disability or death."

      N Engl J Med 2003; 349:11:1013-1014.

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send